Allstate Corporation’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Buy
21,718
+10,436
+93% +$775K 0.02% 665
2025
Q4
$894K Buy
11,282
+5,780
+105% +$443K 0.01% 538
2025
Q3
$402K Buy
+5,502
New +$403K 0.01% 552
2025
Q2
Sell
-6,478
Closed -$493K 585
2025
Q1
$493K Buy
6,478
+2,120
+49% +$158K 0.01% 506
2024
Q4
$288K Buy
+4,358
New +$305K 0.01% 587

Other funds holding SOLV

Allstate Corporation's SOLV Position: Q1 2026 in Review

Allstate Corporation increased its Solventum (SOLV) stake by 93% in Q1 2026, buying an estimated $775K and bringing the position to 21,718 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #665.

Allstate Corporation first reported a position in SOLV in Q4 2024 and has held it in 5 quarters since. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Allstate Corporation held 21,718 shares of Solventum worth $1.42M as of Q1 2026.
  • Allstate Corporation bought 10,436 Solventum shares in Q1 2026, an estimated $775K.
  • Solventum made up 0.02% of Allstate Corporation's portfolio in Q1 2026, its #665 holding.
  • Allstate Corporation first reported a position in Solventum in Q4 2024 and has held it in 5 quarters since.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.